机译:雷公藤多甙联合缬沙坦治疗糖尿病肾病的系统评价与荟萃分析
[1]Department of Chemotherapy 2, Wenzhou Central Hospital, Wenzhou 325000, China;
[2]State Key Laboratory for Diagnosis and Treatment of Infectious Disease, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310000, China;
[3]Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Hangzhou 310000, China;
[4]Department of Cardiology, The Second Affiliated Hospital, Wenzhou Medical University, Wenzhou 325000, China;
[5]Zhuang Medical College, Guangxi University of Chinese Medicine, Nanning 530000, China;
[6]Department of Traditional Chinese Medicine, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325000, China;
[6]Department of Traditional Chinese Medicine, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325000, China;
diabetic nephropathy; meta-analysis; tripterygium glycosides; valsartan;